HDAC9 and cancer: Similar to our finding of selective chromatin change of a fraction of gene loci in ChIP-on-chip, recent studies using cDNA microarrays indicate that several HDAC inhibitors such as TSA, SAHA, MS-275 and depsipeptide alter only 7–20% gene expressions in various cancer cell lines [28]–[30].